Continuous Infusion of Recombinant Factor VIIa (NovoSeven®) in the Treatment of a Patient with Type III von Willebrand’s Disease and Alloantibodies against von Willebrand Factor
Year: 2000
Type: article
Study design: Case Report
Source: Thrombosis and Haemostasis
Authors: U. Geisen, S. Schwender, F. Keller, R.E. Grossmann
Institution: University of Würzburg
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W97520972
